Skip to main content
. 2007 Dec 17;23(5):705–714. doi: 10.1359/JBMR.071212

Table 2.

Baseline Clinical and Biochemical Data in the Study Subjects

Group A (T, −E) Group B (T, +E) Group C (+T,E) Group D (+T, +E) p
n 15 15 15 14
Age (yr) 71 (55, 75) 67 (58, 72) 69 (67, 73) 68 (54, 76) 0.603
Height (m) 1.75 (1.74, 1.79) 1.78 (1.69, 1.83) 1.78 (1.76, 1.84) 1.79 (1.74, 1.82) 0.701
Weight (kg) 84.6 (78.5, 98.7) 86.4 (71.2, 99.6) 88.2 (81.9, 93.5) 87.3 (82.6, 95.4) 0.879
Calcium (mg/dl) 9.4 (9.1, 9.6) 9.6 (9.2, 9.8) 9.4 (9.2, 9.6) 9.3 (9.2, 9.7) 0.467
Phosphorus (mg/dl) 3.4 (3.3, 3.5) 3.5 (3.3, 3.7) 3.2 (3.0, 3.5) 3.2 (2.8, 3.4) 0.128
Bone resorption markers
 Serum CTX (ng/ml) 0.53 (0.36, 0.67) 0.45 (0.38, 0.73) 0.51 (0.30, 0.60) 0.50 (0.33, 0.65) 0.940
 Serum TRACP5b (U/liter) 3.0 (2.6, 3.8) 2.6 (2.1, 3.3) 2.8 (2.5, 3.8) 2.9 (2.6, 3.0) 0.502
 Urine NTX (nmol/d)* 268 (171, 333) 290 (242, 329) 274 (224, 357) 272 (250, 410) 0.644
Bone formation marker
 PINP (μg/liter) 36 (30, 50) 40 (32, 51) 39 (31, 47) 36 (27, 53) 0.880

p value is for comparison across groups by ANOVA. Data are median (IQR).

* Log2 was used.